دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Help Us Help You campaign is no help at all
doi : 10.1016/S1470-2045(22)00757-4
Volume 24, Issue 1, January 2023, Page 1
New evidence for brain cancer risk after a single paediatric CT scan
*Nobuyuki Hamada, Lydia B Zablotska
doi : 10.1016/S1470-2045(22)00696-9
Volume 24, Issue 1, January 2023, Pages 2-3
Bridging the gender gap in childhood cancer: a call to action
*Maya Prasad, Ramandeep Singh Arora
doi : 10.1016/S1470-2045(22)00741-0
Volume 24, Issue 1, January 2023, Pages 3-4
Groundshot: a pan-European, patient-centred, and data-driven approach to tackling cancer
Márcia Costa, David Collingridge
doi : 10.1016/S1470-2045(22)00651-9
Volume 24, Issue 1, January 2023, Pages 5-6
The impact of GDPR on data sharing for European cancer research
Rita T Lawlor
doi : 10.1016/S1470-2045(22)00653-2
Volume 24, Issue 1, January 2023, Pages 6-8
Cancer research in Europe: a focus on children and young people
*Gilles Vassal, Andrew D J Pearson
doi : 10.1016/S1470-2045(22)00641-6
Volume 24, Issue 1, January 2023, Pages 8-9
Inequalities in cancer prevention and care across Europe
*Caroline Berchet, Guillaume Dedet, Niek Klazinga, Francesca Colombo
doi : 10.1016/S1470-2045(22)00746-X
Volume 24, Issue 1, January 2023, Pages 10-11
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma – Authors' reply
*Thomas Powles, Joseph E Burgents, Lei Xu, Toni K Choueiri, on behalf of the KEYNOTE-564 Investigators
doi : 10.1016/S1470-2045(22)00740-9
Volume 24, Issue 1, January 2023, Pages e1-e2
Effective treatment based on monitoring bESR1 mutations
Hoshie Hirai, *Akihiko Shimomura, Dai Kitagawa, Chikako Shimizu
doi : 10.1016/S1470-2045(22)00737-9
Volume 24, Issue 1, January 2023, Page e3
Effective treatment based on monitoring bESR1 mutations – Authors' reply
*Francois-Clément Bidard, Anne-Claire Hardy-Bessard, Suzette Delaloge
doi : 10.1016/S1470-2045(22)00745-8
Volume 24, Issue 1, January 2023, Page e4
Dobbs v Jackson and fertility preservation among adolescents and young adults with cancer
*Lauren Au, Kaylene Au
doi : 10.1016/S1470-2045(22)00684-2
Volume 24, Issue 1, January 2023, Page e5
Treatment-related thoracic soft tissue sarcomas in survivors of breast cancer
Xianglin Hu, Tomohiro Fujiwara, Yangbai Sun, Wending Huang, *Wangjun Yan
doi : 10.1016/S1470-2045(22)00683-0
Volume 24, Issue 1, January 2023, Page e6
Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma
Dun-Chang Mo, Jian-Feng Huang, Peng-Hui Luo, Long Chen, Shang-Xiao Huang
doi : 10.1016/S1470-2045(22)00703-3
Volume 24, Issue 1, January 2023, Page e7
Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma – Authors' reply
Georgina V Long, Jason J Luke, Mizuho Fukunaga-Kalabis, Paolo A Ascierto
doi : 10.1016/S1470-2045(22)00753-7
Volume 24, Issue 1, January 2023, Page e8
Innovative alternatives for metastatic CRPC after enzalutamide
*Camilo A Medina, Cesar Diaz Ritter
doi : 10.1016/S1470-2045(22)00751-3
Volume 24, Issue 1, January 2023, Page e9
Correction to Lancet Oncol 2022; 23: 1133–44
doi : 10.1016/S1470-2045(22)00759-8
Volume 24, Issue 1, January 2023, Page e10
Correction to Lancet Oncol 2023; 24: 91–106
doi : 10.1016/S1470-2045(22)00761-6
Volume 24, Issue 1, January 2023, Page e10
Correction to Lancet Oncol 2023; 24: e11–56
doi : 10.1016/S1470-2045(22)00760-4
Volume 24, Issue 1, January 2023, Page e10
Drug supply issues affecting cancer care in Latin America
Manjulika Das
doi : 10.1016/S1470-2045(22)00734-3
Volume 24, Issue 1, January 2023, Page 12
GPs to get direct access to cancer diagnostic tests
Emma Wilkinson
doi : 10.1016/S1470-2045(22)00735-5
Volume 24, Issue 1, January 2023, Page 13
Tobacco and e-cigarette use remains high among young people in the USA
Roxanne Nelson
doi : 10.1016/S1470-2045(22)00736-7
Volume 24, Issue 1, January 2023, Page 14
Organisations welcome first smoke-free prison in Western Australia
Manjulika Das
doi : 10.1016/S1470-2045(22)00748-3
Volume 24, Issue 1, January 2023, Page 15
England on track to eliminate hepatitis C
Talha Khan Burki
doi : 10.1016/S1470-2045(22)00749-5
Volume 24, Issue 1, January 2023, Page 16
The people behind the numbers: women with breast cancer
Lisa Montel, Veronica Di Carlo, Pamela Minicozzi
doi : 10.1016/S1470-2045(22)00678-7
Volume 24, Issue 1, January 2023, Pages 17-18
New perspectives on the body
Robert Stirrups
doi : 10.1016/S1470-2045(22)00755-0
Volume 24, Issue 1, January 2023, Pages 18-19
Kenji López-Cuevas–Cáncer Warriors de México Foundation
Elizabeth Gourd
doi : 10.1016/S1470-2045(22)00680-5
Volume 24, Issue 1, January 2023, Pages 19-20
ICGC-ARGO precision medicine: an update on targeted therapy based on longitudinal analysis of tumour heterogeneity and evolution in colorectal cancer
Daisuke Kotani, Yoshiaki Nakamura, Takao Fujisawa, Hideaki Bando, Naoya Sakamoto, Amber L Johns, Keunchil Park, ICGC-ARGO†, *Raffaella Casolino, *Takayuki Yoshino, Andrew V Biankin
doi : 10.1016/S1470-2045(22)00650-7
Volume 24, Issue 1, January 2023, Pages 20-21
Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries
Isabelle Soerjomataram, Citadel Cabasag, Aude Bardot, Miranda Marie Fidler-Benaoudia, Adalberto Miranda-Filho, Jacques Ferlay, Donald Maxwell Parkin, Rama Ranganathan, Marion Piñeros, Ariana Znaor, Les Mery, Yvonne Walburga Joko-Fru, Rajesh Dikshit, Rengaswamy Sankaranarayanan, Rajaraman Swaminathan, Freddie Bray, on behalf of the SURVCAN-3 collaborators*
doi : 10.1016/S1470-2045(22)00704-5
Volume 24, Issue 1, January 2023, Pages 22-32
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
Paolo A Ascierto, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Natalia Zhukova, Jacob Schachter, Yibing Yan, Ivor Caro, Christian Hertig, Cloris Xue, Lieke Kusters, Grant A McArthur*, Ralf Gutzmer
doi : 10.1016/S1470-2045(22)00687-8
Volume 24, Issue 1, January 2023, Pages 33-44
Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study
Michael Hauptmann, Graham Byrnes, Elisabeth Cardis, Marie-Odile Bernier, Maria Blettner, Jérémie Dabin, Hilde Engels, Tore S Istad, Christoffer Johansen, Magnus Kaijser, Kristina Kjaerheim, Neige Journy, Johanna M Meulepas, Monika Moissonnier, Cecile Ronckers, Isabelle Thierry-Chef, Lucian Le Cornet, Andreas Jahnen, Roman Pokora, Magda Bosch de Basea, Jordi Figuerola, Carlo Maccia, Arvid Nordenskjold, Richard W Harbron, Choonsik Lee, Steven L Simon, Amy Berrington de Gonzalez, Joachim Schüz, Ausrele Kesminiene
doi : 10.1016/S1470-2045(22)00655-6
Volume 24, Issue 1, January 2023, Pages 45-53
Sex disparity in childhood cancer in India: a multi-centre, individual patient data analysis
Kanu Priya Bhatia, Shuvadeep Ganguly, Archana Sasi, Vivek Kumar, Suryanarayana Deo, Sandeep Agarwala, Venkatraman Radhakrishnan, Rajaraman Swaminathan, Gauri Kapoor, Nalliah Manoharan, Sumit Malhotra, Deepam Pushpam, Sameer Bakhshi
doi : 10.1016/S1470-2045(22)00688-X
Volume 24, Issue 1, January 2023, Pages 54-63
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
Roberto Mina, Pellegrino Musto, Delia Rota-Scalabrini, Laura Paris, Barbara Gamberi, Angelo Palmas, Sara Aquino, Paolo de Fabritiis, Nicola Giuliani, Luca De Rosa, Alessandro Gozzetti, Claudia Cellini, Luca Bertamini, Andrea Capra, Daniela Oddolo, Iolanda Donatella Vincelli, Sonia Ronconi, Vincenzo Pavone, Norbert Pescosta, Michele Cea, Francesca Fioritoni, Stelvio Ballanti, Mariella Grasso, Elena Zamagni, Angelo Belotti, Mario Boccadoro, Francesca Gay
doi : 10.1016/S1470-2045(22)00693-3
Volume 24, Issue 1, January 2023, Pages 64-76
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
Stephen R D Johnston, Masakazu Toi, Joyce O’Shaughnessy, Priya Rastogi, Mario Campone, Patrick Neven, Chiun-Sheng Huang, Jens Huober, Georgina Garnica Jaliffe, Irfan Cicin, Sara M Tolaney, Matthew P Goetz, Hope S Rugo, Elzbieta Senkus, Laura Testa, Lucia Del Mastro, Chikako Shimizu, Ran Wei, Ashwin Shahir, Maria Munoz, Belen San Antonio, Valérie André, Nadia Harbeck, Miguel Martin, on behalf of the monarchE Committee Members*
doi : 10.1016/S1470-2045(22)00694-5
Volume 24, Issue 1, January 2023, Pages 77-90
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
José Garcia-Pelaez, Rita Barbosa-Matos*, Silvana Lobo*, Alexandre Dias*, Luzia Garrido, Sérgio Castedo, Sónia Sousa, Hugo Pinheiro, Liliana Sousa, Rita Monteiro, Joaquin J Maqueda, Susana Fernandes, Fátima Carneiro, Nádia Pinto, Carolina Lemos, Carla Pinto, Manuel R Teixeira, Stefan Aretz, Svetlana Bajalica-Lagercrantz, Judith Balmaña, Ana Blatnik, Patrick R Benusiglio, Maud Blanluet, Vincent Bours, Hilde Brems, Joan Brunet, Daniele Calistri, Gabriel Capellá, Sergio Carrera, Chrystelle Colas, Karin Dahan, Robin de Putter, Camille Desseignés, Elena DomÃnguez-Garrido, Conceição Egas, D Gareth Evans, Damien Feret, Eleanor Fewings, Rebecca C Fitzgerald, Florence Coulet, MarÃa Garcia-Barcina, Maurizio Genuardi, Lisa Golmard, Karl Hackmann, Helen Hanson, Elke Holinski-Feder, Robert Hüneburg, Mateja Krajc, Kristina Lagerstedt-Robinson, Conxi Lázaro, Marjolijn J L Ligtenberg, Cristina MartÃnez-Bouzas, Sonia Merino, Geneviève Michils, Srdjan Novaković, Ana Patiño-GarcÃa, Guglielmina Nadia Ranzani, Evelin Schröck, Inês Silva, Catarina Silveira, José L Soto, Isabel Spier, Verena Steinke-Lange, Gianluca Tedaldi, MarÃa-Isabel Tejada, Emma R Woodward, Marc Tischkowitz, Nicoline Hoogerbrugge, Carla Oliveira
doi : 10.1016/S1470-2045(22)00643-X
Volume 24, Issue 1, January 2023, Pages 91-106
Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study
Colin Y C Lee, Adriaan Olivier, Judith Honing, Anne-Marie Lydon, Susan Richardson, Maria O’Donovan, Marc Tischkowitz, Rebecca C Fitzgerald, Massimiliano di Pietro
doi : 10.1016/S1470-2045(22)00700-8
Volume 24, Issue 1, January 2023, Pages 107-116
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
Mark Lawler, Lynne Davies, Simon Oberst, Kathy Oliver, Alexander Eggermont, Anna Schmutz, Carlo La Vecchia, Claudia Allemani, Yolande Lievens, Peter Naredi, Tanja Cufer, Ajay Aggarwal, Matti Aapro, Kathi Apostolidis, Anne-Marie Baird, Fatima Cardoso, Andreas Charalambous, Michel P Coleman, Alberto Costa, Mirjam Crul, Csaba L Dégi, Federica Di Nicolantonio, Sema Erdem, Marius Geanta, Jan Geissler, Jacek Jassem, Beata Jagielska, Bengt Jonsson, Daniel Kelly, Olaf Kelm, Teodora Kolarova, Tezer Kutluk, Grant Lewison, Françoise Meunier, Jana Pelouchova, Thierry Philip, Richard Price, Beate Rau, Isabel T Rubio, Peter Selby, Maja Južni� Sotlar, Gilliosa Spurrier-Bernard, Jolanda C van Hoeve, Eduard Vrdoljak, Willien Westerhuis, Urszula Wojciechowska, Richard Sullivan
doi : 10.1016/S1470-2045(22)00540-X
Volume 24, Issue 1, January 2023, Pages e11-e56
Chest mass in a transgender man after top surgery
Chandler S Cortina, Amanda L Kong
doi : 10.1016/S1470-2045(22)00545-9
Volume 24, Issue 1, January 2023, Page e57
